Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;48(7):683-92.
doi: 10.1002/ppul.22766. Epub 2013 Feb 8.

Validation of novel wheeze phenotypes using longitudinal airway function and atopic sensitization data in the first 6 years of life: evidence from the Southampton Women's survey

Affiliations

Validation of novel wheeze phenotypes using longitudinal airway function and atopic sensitization data in the first 6 years of life: evidence from the Southampton Women's survey

Samuel A Collins et al. Pediatr Pulmonol. 2013 Jul.

Abstract

Background: In 1995 the Tucson Children's Respiratory Study (TCRS) identified clinically distinct phenotypes amongst early wheezers; the Avon Longitudinal Study of Parents And Children (ALSPAC) has recently re-examined these.

Objectives: To validate statistically derived ALSPAC phenotypes in the Southampton Women's Survey (SWS) using infant and 6-year lung function, and allergic sensitization at 1, 3, and 6 years, comparing these with TCRS phenotypes.

Methods: Complete 6-year follow-up data were available for 926 children, selected from 1,973 infants born to 12,579 women characterized pre-conception. Ninety-five children had V'maxFRC and FEV0.4 measured age 5-14 weeks using rapid compression/raised volume techniques. At 6 years we performed spirometry (n = 791), fractional exhaled nitric oxide (FeNO, n = 589) and methacholine challenge (n = 234). Skin prick testing was performed at 12m, 3 and 6 years (n = 1,494, 1,255, 699, respectively). Using wheeze status questionnaire data at 6m, 12m, 2, 3 and 6 years we classified children into TCRS (never, transient early, persistent, late-onset) and ALSPAC based groups (never, early, transient, intermediate-onset, late-onset, persistent).

Results: Amongst ALSPAC groups, persistent and late-onset wheeze were associated with atopy at 3 and 6 years, whilst intermediate-onset wheeze showed earlier atopic association at 1 year; all three were associated with FeNO at 6 years. Persistent wheezers had lower infant (V'maxFRC P < 0.05) and 6-year lung function (FEV1, FEV1/FVC, and FEF(25-75), P < 0.05), whilst late and intermediate-onset wheezers showed no lung function deficits. Transient wheezers were non-atopic but showed persistent lung function deficits (V'maxFRC in infancy, FEV1 and FEF(25-75) at 6 years, all P < 0.05). Those who wheezed only in the first year (early phenotype) showed no lung function deficits. No associations were seen with 6 years bronchial hyper-responsiveness or infancy FEV0.4.

Conclusion: SWS cohort data validates the statistically derived ALSPAC six-class model. In particular, lung function and atopy successfully differentiate persistent, late-onset and intermediate-onset wheeze, whilst the Tucson "transient early" wheeze phenotype can be sub-classified into groups that reflect early lung function. Since the 4-class model fails to adequately differentiate phenotypes based on lung function and atopy, we propose that strong consideration be given to using the 6-class paradigm for longitudinal outcome work in wheezing with onset in early life.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram showing numbers in follow-up groups at each age and number who had skin prick testing and lung function measurements.
Figure 2
Figure 2
Venn diagram showing distribution of children amongst Tucson groups (black circle) and ALSPAC groups (grey circles)
Figure 3
Figure 3
Graph showing tracking of internal z scores for each ALSPAC phenotype for a) maximal flow at functional residual capacity (V’maxFRC) in infancy and forced expiratory flow at 25-75% vital capacity (FEF25-75) at 6 years of age, b) forced expiratory volume in 0.4 seconds (FEV0.4) in infancy and forced expiratory volume in 1 second (FEV1) at 6 years of age and c) tracking of relative risk (RR) of atopy at 1, 3 and 6 years.

References

    1. Martinez FD, Wright AL, Taussig LM, et al. The Group Health Medical Associates Asthma and wheezing in the first six years of life. N Engl J Med. 1995;332:133–8. - PubMed
    1. Sandin A, Björkstén B, Bråbäck L. Development of atopy and wheezing symptoms in relation to heredity and early pet keeping in a Swedish birth cohort. Pediatr Allergy Immunol. 2004;15:316–22. - PubMed
    1. Kurukulaaratchy RJ, Fenn M, Twiselton R, et al. The prevalence of asthma and wheezing illnesses amongst 10-year-old schoolchildren. Respir Med. 2002;96:163–9. - PubMed
    1. Illi S, von Mutius E, Lau S, et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet. 2006;368:763–70. - PubMed
    1. Brussee JE, Smit Ha, van Strien RT, et al. Allergen exposure in infancy and the development of sensitization, wheeze, and asthma at 4 years. J Allergy Clin Immunol. 2005;115:946–52. - PubMed

Publication types

MeSH terms